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Abstract
Background: Vibrio cholerae is the causal intestinal pathogen of the diarrheal disease cholera. It secretes the protease PrtV,
which protects the bacterium from invertebrate predators but reduces the ability of Vibrio-secreted factor(s) to induce
interleukin-8 (IL-8) production by human intestinal epithelial cells. The aim was to identify the secreted component(s) of V.
cholerae that induces an epithelial inflammatory response and to define whether it is a substrate for PrtV.
Methodology/Principal Findings: Culture supernatants of wild type V. cholerae O1 strain C6706, its derivatives and pure V.
cholerae cytolysin (VCC) were analyzed for the capacity to induce changes in cytokine mRNA expression levels, IL-8 and
tumor necrosis factor-a (TNF-a) secretion, permeability and cell viability when added to the apical side of polarized tight
monolayer T84 cells used as an in vitro model for human intestinal epithelium. Culture supernatants were also analyzed for
hemolytic activity and for the presence of PrtV and VCC by immunoblot analysis.
Conclusions/Significance: We suggest that VCC is capable of causing an inflammatory response characterized by increased
permeability and production of IL-8 and TNF-a in tight monolayers. Pure VCC at a concentration of 160 ng/ml caused an
inflammatory response that reached the magnitude of that caused by Vibrio-secreted factors, while higher concentrations
caused epithelial cell death. The inflammatory response was totally abolished by treatment with PrtV. The findings suggest
that low doses of VCC initiate a local immune defense reaction while high doses lead to intestinal epithelial lesions.
Furthermore, VCC is indeed a substrate for PrtV and PrtV seems to execute an environment-dependent modulation of the
activity of VCC that may be the cause of V. cholerae reactogenicity.
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Introduction
Vibrio cholerae, the causal organism of the diarrheal disease
cholera, is a Gram-negative motile bacterium acquired via intake
of contaminated food or water. Secreted cholera toxin (CTX) is
the major factor that causes diarrhea. However, most V. cholerae
vaccine candidates lacking CTX still exhibit reactogenicity in
clinical trials [1–4]. The molecular and cellular mechanisms
behind these adverse effects are still unknown. Levine et al. [5]
suggested that a previously unidentified enterotoxin could cause
symptoms in the absence of CTX, but its existence has been
masked by the activity of CTX in the virulent strains. Proposed
candidates are the Hap protease [6,7], the multifunctional
autoprocessing RTX toxin [8], and Vibrio cholera cytolysin
(VCC), also called hemolysin A and El Tor hemolysin [9].
Using reverse molecular genetics in the V. cholerae O1 strain
C6706, we showed that a previously uncharacterized extracellular
Zn
2+-binding metalloprotease, PrtV, confers protection against
grazing by natural bacteriovorous predators such as flagellates
and ciliates [10,11]. Furthermore, PrtV was found to be essential
for bacterial killing of the nematode Caenorhabditis elegans,a
phenomenon associated with colonization of the C. elegans
intestine [10]. We hypothesized that the PrtV protease also
actively contributes to the gut inflammation seen in volunteers in
cholera vaccine trials, possibly by inducing an inflammatory
response with secretion of the chemokine interleukin-8 (IL-8) by
epithelial cells. However, by using polarized tight monolayers of
the intestinal epithelial cell line T84 as an in vitro model for human
intestinal epithelium, our results suggested that PrtV is not an IL-8
stimulator in man, but instead reduces the IL-8-inducing activity
of an as yet unidentified secreted component(s) of V. cholerae [10].
In order to understand the intriguing contrasting effects of PrtV in
man compared to invertebrates, we aimed at identifying secreted
component(s) of V. cholerae that induces an epithelial inflammatory
response and define whether the active component(s) isa substrate
for PrtV.
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Luria-Bertani (LB) Culture Supernatants of V. cholerae
C6706 PrtV Deletion Mutants Cause an IL-8-Dominated
Inflammatory Response in Human Intestinal Epithelial Cells
Initially, the possibility that PrtV directly affects the intestinal
epithelium was addressed. LB broth supernatants from overnight
cultures of V. cholerae C6706 (C6706wt) and the PrtV deletion
mutant (DprtV) [10] were added to the apical side of tight
monolayers of polarized T84 cells as in vitro model for human
intestinal epithelium. Permeability was assessed as transepithelial
electrical resistance (TER) and the average expression levels/cell of
mRNA for the pro-inflammatory cytokines IL-8, IL-6, and tumor
necrosis factor-a (TNF-a) and the down-regulatory, wound-healing,
and ‘‘epithelium-sealing’’ cytokine transforming growth factor-b1
(TGF-b1) weredetermined. TERstayed highin tight monolayers to
which LB broth alone or culture supernatant from C6706wt had
been added (Fig. 1a). In contrast, culture supernatants from DprtV
caused a significant drop in TER, i.e., 12.561.1% of that in the LB
broth control, suggesting a significant increase in permeability
(Fig. 1a). mRNA expression levels in LB broth controls were low for
IL-6 and TNF-a (mean6SD, 0.00160.0001 and 0.03760.006
mRNA copies/18S rRNA unit for IL-6 and TNF-a, respectively,
n=3), intermediate for IL-8 (4.664.3 mRNA copies/18S rRNA
unit, n=3) and high for TGF-b1 (33.665.2 mRNA copies/18S
rRNA unit, n=3). Supernatant from DprtV caused a more than 20-
fold increase of IL-8 and TNF-a mRNA levels while supernatant
from C6706wt caused only marginal increases both cytokines
(Fig. 1b, c). In contrast, IL-6 and TGF-b1 mRNA levels did not
change upon exposure to culture supernatants from DprtV or
C6706wt (data not shown). Deletion of CTX or both CTX and
PrtV did not cause any changes compared to C6706wt in capability
to secrete factors that influenced permeability and/or cytokine
mRNA levels in tight monolayers (data not shown).
PrtV Does Not Inactivate Pro-Inflammatory Factor(s)
when the Bacteria Are Cultured in Brain/Heart Infusion
(BHI) Broth
Unexpectedly, the supernatants from C6706wt caused a
significant drop in TER (Fig. 2a) and increases in IL-8 and
TNF-a mRNA levels (Fig. 2b, c) when the bacteria were cultured
in BHI broth instead of LB (Fig. 2a–c). These changes were
comparable to those of tight monolayers incubated with
supernatants from DprtV cultured in BHI (Fig. 2a–c) or LB
(Fig. 1a–c). The elevated IL-8 mRNA levels were accompanied by
secretion of IL-8 protein to the culture medium at the basolateral
side of the tight monolayers (Fig. 2d). The magnitude of these
responses was similar to that of tight monolayer cells exposed to
supernatants from DprtV cultured in LB, suggesting that BHI broth
in some way inhibits PrtV degradation of the factor(s) causing the
inflammatory response. Secreted TNF-a protein could not be
detected by the same method (data not shown). In addition,
culture supernatants of the non-01/non-0139 strain V11 caused a
stronger inflammatory response when the bacterial strain was
grown in BHI broth compared to LB broth (see Supplementary
Text S1 and Figure S1) suggesting that this could be a universal
feature of VCC secreting Vibrio strains. The stronger inflammatory
response correlated with larger amounts of secreted VCC when
the bacteria were grown in BHI broth (Figure S2).
Experiments with Deletion Mutants Suggest that VCC Is
the Factor Causing an Inflammatory Response in
Epithelial Cells and that PrtV Is the Major Factor Causing
Its Inactivation
Tight monolayers challenged with BHI broth supernatants from
the VCC deletion mutant (Dvcc; Table 1) and the PrtV/VCC
double deletion mutant (DprtV/Dvcc; Table 1) retained the same
high TER as the BHI broth control while tight monolayers
incubated with supernatants from DprtV showed a highly
significant decrease in TER (Fig. 2a). Both IL-8 production
(Fig. 2b,d) and TNF-a mRNA levels remained close to the levels of
the BHI-broth control (Fig. 2b–d). These results suggest that VCC,
but not PrtV, is the factor inducing an inflammatory response.
That PrtV is the major component causing degradation of VCC is
indicated by the fact that supernatants from a derivative carrying
an in-frame deletion mutation in the gene coding for a regulator of
V. cholerae protease expression (DhapR; Table 1) caused the same
changes in TER and IL-8 production as DprtV (Fig. 2a,b,d),
although several proteases in addition to PrtV are inactivated by
deletion of the HapR gene. TGF-b1 and IL-6 mRNA levels were
Figure 1. Tight monolayer responses to factors secreted by wt and DprtV V. cholerae in LB broth. Transepithelial electrical resistance (TER)
(a) and IL-8 (b), and TNF-a (c) mRNA expression levels in polarized tight monolayers of T84 intestinal epithelial cells challenged with culture
supernatants from wild type V. cholerae strain C6707 (C6706wt) and the PrtV deletion mutant (DprtV) cultured in LB broth at the apical side for
5 hours at 37uC. TER is expressed as percentage of TER before incubation with the supernatant, calculated as [(TER after 5 hours incubation/TER at
onset of incubation) x 100] for the individual wells. Cytokine mRNA expression levels were determined by real-time quantitative RT-PCR with RNA
copy standards and normalized to the amount of 18S rRNA in the respective sample, giving an estimate of the average number of mRNA copies per
cell. Bars and whiskers represent mean +1SD of three independent experiments. Statistically significant changes from LB controls as estimated by
two-sided Student’s t-test are indicated. ** p-value ,0.01.
doi:10.1371/journal.pone.0007806.g001
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mutant bacteria cultured in BHI (data not shown).
The PrtV Protease Affects V. cholerae Hemolytic Activity
by Influencing VCC Stability
Our results suggest that PrtV influences an inflammatory
activity of VCC on epithelial cells. Therefore we tested whether
PrtV would influence the hemolytic activity of VCC. Using
supernatants of C6706wt, DprtV and DhapR grown in LB, we
monitored the capacity to induce hemolysis of rabbit red blood
cells. Hemolytic activity was enhanced in the case of mutant
derivatives defective in the PrtV protease expression or the HapR
regulator (Fig. 3a). These results suggested that PrtV protease
modulated VCC hemolytic activity by means of proteolytic action.
Culture supernatants from bacteria grown in BHI broth showed
higher hemolytic activity in comparison to supernatants from
bacteria grown in LB (Fig. 3b). In line with the epithelial cell tight
monolayer experiments, the hemolytic activity of C6706wt was
high, and no increase was seen with any of the mutants when the
bacteria were grown in BHI broth, although a significant increase
in hemolytic activity was observed when the bacteria were grown
in LB (Fig. 3a,b). It remains to be analyzed how BHI broth can
influence the synthesis of proteases in V. cholerae.
DprtV Supernatant Contains More VCC than C6706wt
Supernatant when Cultured in LB Broth
In order to analyze the secreted VCC levels of C6706wt and its
derivatives, we performed immunoblot analyses using anti-VCC
antiserum. The level of secreted PrtV was monitored using anti-
PrtV antiserum. In the absence of the PrtV (DprtV) and the positive
regulator of the secreted proteases, HapR (DhapR), the level of
VCC was clearly increased compared with the wild type strain
C6706 (C6706wt; Fig. 4a). Deletion of the gene encoding the
LuxO regulator (DluxO) causes increased HapR levels in V. cholerae,
resulting in overproduction of several proteolytic enzymes [10,12]
that could degrade the VCC cytolysin. Consistent with this, the
VCC levels in DluxO were dramatically reduced both in LB and
BHI media (Fig. 4a).
Figure 2. Tight monolayer responses to factors secreted by V. cholerae and mutant derivates in BHI broth. TER (a), expression levels of
IL-8 (b) and TNF-a (c) mRNAs and amounts of IL-8 protein secreted (d) by polarized tight monolayer cells challenged with BHI broth culture
supernatants from C6706wt, and deletion mutants for PrtV (DprtV), VCC (Dvcc), both PrtV and VCC (DprtVDvcc) and HapR (DhapR). Challenge with
supernatants and TER and cytokine mRNA level determinations as in Figure 1. IL-8 protein is given as the concentration determined by ELISA in the
culture medium from the lower chamber of tight monolayers after subtraction of the concentration in the BHI control in the respective experiment.
Bars and whiskers represent mean + 1SD of 3 independent experiments. Statistically significant changes from BHI controls as estimated by two-sided
Student’s t-test are indicated. * p-value #0.05, ** p-value ,0.01, and *** p-value ,0.001.
doi:10.1371/journal.pone.0007806.g002
Table 1. Bacterial strains utilized.
Strain Relevant genotype/phenotype References
V. cholerae C6706 El Tor, Inaba, Strep
R 28




KVQ1 C6706 str2 DhapR 10
KVQ2 C6706 str2 DluxO 10
KAS122 C6706 str2 DprtV 10
BML30 C6706 str2 Dvcc This study
PKR1 C6706 str2 Dvcc DprtV This study
SNW50 C6706 ctx::km This study
SNW51 C6706 ctx:.km DprtV This study
doi:10.1371/journal.pone.0007806.t001
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Response in Intestinal Epithelial Cells
The question of whether VCC could be a factor causing the
inflammatory response in epithelial cells was addressed by
incubating tight monolayers with serial dilutions of the purified
VCC protein at concentrations from 0.26 ng/ml to 20 mg/ml. As
little as 6.4 ng/ml VCC caused a significant drop in TER (Fig. 5a).
VCC did not cause cell death, measured as lactate dehydrogenase
(LDH) release, at this concentration, while significant cell death
was seen at VCC concentrations of 800 ng/ml and above (Fig. 5a).
The levels of IL-8 and TNF-a mRNAs increased with increasing
amounts of VCC, up to 160 ng/ml, and reached the levels in tight
monolayers incubated with supernatants of DprtV or C6706wt
cultured in BHI (Fig. 5b,c). Increased IL-8 and TNF-a mRNA
levels were inversely correlated to TER up to this point. At higher
VCC concentrations, a decrease in cytokine mRNA levels was
observed that paralleled the increase in cell death (Fig. 5a–c). VCC
had no influence on IL-6 mRNA levels (not shown). Notably, at
the VCC concentration where the IL-8 and TNF-a response was
strongest, there was a marked drop in TER without any increase
in cell death (Fig. 5a–c).
VCC Is a Substrate for the PrtV Protease and PrtV
Modulates the Pro-Inflammatory Effect of VCC
In vitro experiments with both PrtV and VCC included as
purified proteins effectively ruled out the possibility that some
other bacterial component could be responsible for cleavage of
VCC. The VCC protein was rapidly digested into a series of
polypeptides that appeared smaller than 45 kDa, and within 5
minutes the majority of the VCC protein was degraded (Fig. 4b).
These results fully support the suggestion that PrtV is the major
protease responsible for reducing the cytolytic and hemolytic
activities of V. cholerae. Thus, PrtV may also moderate the
inflammatory effects through degradation of VCC. This possibility
was addressed by treating pure VCC protein with pure PrtV
before addition to the polarized tight monolayers, using the VCC
concentration that yielded optimal inflammatory effect. Monolay-
ers incubated with VCC and PrtV only were run in parallel. TER,
LDH release, IL-8 mRNA and TNF-a mRNA levels and amounts
of secreted IL-8 protein were determined and compared to LB-
broth controls. In line with previous experiments, VCC alone
caused a significant drop in TER without measurable cell death
(Fig. 6a and not shown), increased IL-8 mRNA and protein levels
(Fig. 6b,d), and TNF-a mRNA levels (Fig. 6c). The effects on
TER, IL-8, and TNF-a were all abolished by PrtV treatment
(Fig. 6a–d). PrtV alone did not induce changes in any of these
parameters (Fig. 6a–d). Thus, PrtV degradation of VCC seems to
play a role in modulating reactogenicity of V. cholerae.
Discussion
This study emerged from the previous, intriguing results of
reverse molecular genetics experiments suggesting that the Vibrio
protease PrtV confers an ‘‘anti-infammatory’’, seemingly protec-
tive effect on human intestinal epithelium while it exerts a
Figure 3. Hemolytic activity of secreted factors from wild type
V. cholerae and deletion mutant derivates. Culture supernatants of
C6706wt, DprtV, and DhapR were serially diluted and tested for
hemolytic activity. (a) Bacteria grown in LB broth. (b) Bacteria grown in
BHI broth. Bars and whiskers represent mean + 1SD of 3 independent
experiments. Statistically significant changes from C6707wt at each
dilution as estimated by one-way ANOVA are indicated. * p-value #0.05
and ** p-value ,0.01.
doi:10.1371/journal.pone.0007806.g003
Figure 4. Analyses of VCC degradation by PrtV. (a) Immunoblot
analyses of proteins from 1 ml samples of 24 hours culture superna-
tants of C6707wt, DprtV, DhapR, DluxO and Dvcc grown in BHI or LB
broth as indicated using anti-VCC (upper rows) and anti-PrtV (lower
rows) antisera. Three mg protein was applied to each lane. (b) SDS-PAGE
and Coomassie blue staining of pure VCC protein (0.4 mg/ml)
incubated with pure PrtV protease (50 nM) for 1 min (lane 2), 5 min
(lane 3), 15 min (lane 4), 30 min (lane 5), 60 min (lane 6), and 120 min
(lane 7). Lane 8: VCC incubated for 120 min without PrtV. (M) = protein
molecular weight markers.
doi:10.1371/journal.pone.0007806.g004
Inflammation by V. cholerae
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We found that PrtV executes its anti-inflammatory action by
degrading secreted VCC and that BHI broth somehow protects
VCC from degradation by PrtV. The latter finding was
underscored by the consistent, parallel changes in capacity to
induce an inflammatory response in intestinal epithelial cells and
to cause lysis of red blood cells in bacterial culture supernatants
depending of type of broth used, i.e. supernatants of wild type
bacteria grown in LB caused little hemolysis and a low
inflammatory response while supernatants of bacteria grown in
BHI caused extensive hemolysis and a strong inflammatory
response. The inflammatory response was characterized by
Figure 5. Effects of VCC on permeability, cell viability and cytokine levels in intestinal epithelium tight monolayers. TER (a, left y-axis),
cytolysis (LDH release) (a, right y-axis), and IL-8 (b) and TNF-a (c) mRNA levels in polarized tight monolayer cells challenged with serial dilutions of
pure VCC protein in LB broth at the apical side for 5 hours at 37uC. Results are from 3 independent experiments and presented as mean 61 SD for
each concentration. Rectangles indicate results at 160 ng VCC/ml.
doi:10.1371/journal.pone.0007806.g005
Figure 6. PrtV abolishes VCC induced increases in permeability and cytokine production in intestinal epithelium tight monolayers.
TER (a) and IL-8 (b) and TNF-a (c) mRNA levels in polarized tight monolayer cells and amounts of IL-8 protein secreted (d) upon challenge with
160 ng/ml of pure VCC (VCC), VCC treated with PrtV, as in Figure 4b, for 30 min and thereafter diluted to 160 ng VCC/ml and 0.02 nM PrtV
(VCC+PrtV), and 0.02 nM pure PrtV (PrtV) in LB broth. (LB) = LB broth control. Bars and whiskers represent mean + 1SD of 3 independent
experiments. Statistically significant changes from LB broth controls are indicated. ** p-value ,0.01, and *** p-value ,0.001.
doi:10.1371/journal.pone.0007806.g006
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amounts of TNF-a by the epithelial cells. Experiments with pure
VCC protein showed that VCC alone is likely to be responsible for
these effects. Thus, VCC could be the causative agent of several
symptoms induced by CTX-deficient strains of V. cholerae. In line
with this notion, Debellis et al. [13] recently reported that VCC
can cause decreased trans-tissue electrical resistance and increased
chloride secretion when added at the luminal side of human colon
mucosa specimens stripped of mucous layer.
VCC at concentrations above 160 ng/ml caused death of
epithelial cells. However already at lower concentrations there
were significant increases in permeability that could reflect
paracellular leakage due to decreased tight junction stability.
Since VCC acts by forming transmembrane pores, it is also
possible that the epithelial cells lose cellular integrity due to
difficulties in maintaining intracellular homeostasis. It is notewor-
thy that VCC transmembrane pores are too small (1.2 nm in inner
diameter) to allow passage of proteins while ions easily could pass
through [14].
VCC is an exotoxin produced by most O1 biotype El Tor and
non-O1/non-O139 V. cholerae isolates [9,15]. It is secreted as an
inactive 80 kDa pro-toxin and processed by proteolytic cleavage
into a 65 kDa active cytolysin [16–18], which can assemble into
transmembrane pores in eukaryotic cells [14]. This toxin causes
vacuolization, necrosis, or autophagy depending on the cell type
and toxin concentration [19–24]. The VCC protein is rapidly
lethal for mice after intravenous administration [8]. Olivier et al.
described VCC as a causal factor of the tissue damage that occurs
in the small intestinal epithelium in an adult mouse infection
model [8]. Our results confirm that VCC efficiently lyses red blood
cells and show that VCC also can kill human intestinal epithelial
cells in polarized tight monolayers. Thus, VCC might cause
serious damage both at the intestinal epithelial lining and in the
blood. Notably, lower non-toxic doses of VCC induced an
inflammatory response in intestinal epithelial cells that included
increased epithelial permeability and induction of IL-8 and TNF-
a, This suggests that intestinal epithelial cells initially execute a
front-line defense to V. cholerae infection which is induced by VCC
and involves recruitment of immune cells to the infected site by IL-
8 and activation of epithelial cells, intraepithelial lymphocytes, and
lamina propria macrophages by TNF-a. In this system, VCC
seems to account for virtually all of the stimulation caused by V.
cholerae secreted factors. It has been proposed that VCC has a role
in the pathogenesis of gastroenteritis, particularly in strains that do
not produce CTX [25]. Our results are compatible with this
notion, although it is not known to what extent an epithelial
inflammatory response contributes to the symptoms. CTX, which
clearly is involved in cholera diarrhea, did not contribute to the
inflammatory response in the tight monolayer cells, which is in
agreement with a previous report [26]. It is important to keep in
mind that the intestinal epithelial cells are polarized and receptors
for bacterial components like the TLRs are preferentially localized
to the basolateral side in vivo [27]. This is also likely to be the case
in the in vitro model used here. Thus, once the bacterium and/or
its released factors have penetrated the epithelial barrier into the
tissues, additional mechanisms may come into play.
The present finding that the inflammatory response is almost
completely abolished by PrtV degradation of VCC suggests that
VCC is indeed an autologous substrate for PrtV and that it is
involved in modulation of V. cholerae reactogenicity. The reason the
bacterium modulates its toxicity at the level of secreted proteins
rather than at the transcriptional level is not known. It might be
that this is an adaptation to achieve the best strategy for different
environmental conditions. In line with this notion, VCC
degradation by PrtV was inhibited by yet undefined factor(s) in
the more complex bacterial culture media. Thus, VCC was spared
from proteolysis when wild type V. cholerae was grown in BHI broth
but degraded when the bacteria were grown in LB. Accordingly,
the capacity to induce an inflammatory response in tight
monolayer cells and to lyse red blood cells was only observed
when the bacteria were grown in BHI medium or were PrtV-
deficient. BHI seems to influence the overall functional state of the
bacteria since the total amount of secreted V. cholerae proteases is
reduced in BHI broth (not shown). Furthermore, BHI could
contain a chelator, depriving the medium of divalent ions, thereby
inactivating PrtV, and/or be rich in other substrates for PrtV
proteolysis, thereby sparing VCC. The content of the gut lumen is
likely to be more similar to BHI than to LB and consequently
degradation of VCC would be minimal, which would give the
opportunity for VCC to exert its toxic effects at the epithelial lining
and subsequently allow access of the bacteria to the bodily tissues.
Materials and Methods
Bacterial Strains
Bacterial strains and mutant constructions used are listed in
Table 1. A Dvcc mutant was constructed by crossover PCR
essentially as described previously [10,12,28]. Briefly, a 500 bp 59
flanking sequence of the gene including several nucleotides of the
coding region was PCR amplified with the primers vcc-A (59-
CGCTCTAGACCTTGGAGTTGCAGGTAGGC-39)a n dvcc-B
(59-TGTTAGTTTATAGTGGATGGGGGTTGGACTGGATA-
TTGCGC-39). The primers vcc-C (59-CCCATCCACTATAAAC-
TAACAGCAAGCTTGCAACGTCTCTC-39) and vcc-D (59-CG-
CTCTAGACCTTGTTGCGATAACGCGTGA-39) were used to
amplify several nucleotides of the 39 region of the gene plus 500 bp
of the downstream flanking sequence. The two PCR products were
annealed at their overlapping region and amplified by PCR to
produce a DNA single fragment, using the outer primers (vcc-A and
vcc-D). The resulting PCR product, lacking most of the coding
sequence of the gene, was digested with XbaI enzyme and ligated
into similarly a digested pCVD442 suicide plasmid. The
pCVD442::Dvcc was introduced into E. coli SM10lpir by
electroporation. The donor E. coli S10lpir containing the plasmid
pCVD442::Dvcc was used for conjugal transfer to a rifampicin-
resistant V. cholerae O1 El Tor C6706 strep
R or DprtV strain. A
mixture containing equal volumes of the donor and recipient in LB
was incubated for 6 h at 30uC. The exconjugants were selected by
plating the suspension onto LB plates supplemented with 100 mg/
ml of streptomycin (strep) and 100 mg/ml of carbenicillin (Cb) and
incubated at 30uC. After selection of the desired transconjugants on
strep+Cb plates, they were streaked onto LB-plates with 10%
sucrose and incubated at 30uC. Several colonies were purified from
the plates, tested for Cb sensitivity and then analyzed for the
deletion by using colony PCR.
The ctx::km and ctx::kmDprtV mutant were obtained by phage-
mediated transduction using the CP-T1ts phage [29]. The CP-
T1ts stock was obtained from Dr. Andrew Camilli. Bacteriophage
CP-T1ts propagated in a strain derived from E7946::km were
prepared by the plate method. V. cholerae cells were grown to late-
exponential phase (OD 600,0.7), and infected at a multiplicity of
infection of 10
25 with CP-T1ts. Bacteriophage were allowed to
adsorb 10 min at room temperature, then mixed with 5 ml of
45uC LB soft agar (0.5%) and poured onto LB agar plates. The
plates were incubated at 30uC. Bacteriophage were recovered
from the soft agar layer of plates by resuspending the top agar in
5 ml of LB broth and incubated at 4uC to allow bacteriophage
diffusion. Agar and bacteria were removed by two successive
Inflammation by V. cholerae
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concentrated by centrifugation at 16,000 x g for 2 h at 4C. The
pellet containing bacteriophage were suspended in 500 mlo fL B
broth and used for transduction. Phage transduction was done as
follows: the recipient strains (C6706 and DprtV) were grown in
10 ml LB to late-exponential phase (OD 600,0.7), spun down
and resuspended in 1 ml LB broth. One half ml of the bacterial
suspension, 0.5 ml of phage suspension and 0.5 ml of adsorption
buffer (0.015 M CaCl2 + 0.03 M MgCl2) were mixed and
incubated at 30uC for 20 min. The cells were washed once in
0.9% NaCl, spun down and resuspended in 0.3 ml of NaCl. One
hundred ml samples of the suspension were spread out on plates
containing 30 mg/ml kanamycin (Sigma). Transductant colonies
were purified and used for further experiments.
Bacteria were grown overnight at 37uC with shaking in 20 ml of
LB or BHI broth supplemented, as appropriate, with kanamycin
(30 mg/ml) or ampicillin (50 mg/ml).
Bacterial Proteins
The purification of VCC and PrtV from V. cholerae was
described in [18] and [11], respectively. To test the proteolytic
activity of PrtV on VCC, pure VCC protein (0.4 mg/ml) was
incubated with 100 nM pure PrtV protein in 50 mM HEPES,
1 mM CaCl2 and 1 mM MgCl2 (pH 7.2) at 37uC.
Intestinal Epithelial Cell Tight Monolayer Cultures
Polarized tight monolayers of the established human colon
carcinoma cell line T84 (American Type Culture Collection,
Rockville, MD, USA) were established on semi-permeable
membrane supports as described [30]. Tissue culture medium in
the upper chamber was replaced by culture supernatants from
different bacterial strains grown in LB or BHI broth or serial
dilutions of VCC and PrtV proteins in LB when a TER of
$1,000 Ohm/cm
2 was obtained. Monolayers were thereafter
incubated at 37uCi n5 %C O 2 for 5 hours, at which time TER was
measured, culture supernatants were collected for LDH release
and cytokine protein analysis, and tight monolayer cells were
collected in 4 M guanidinium thiocyanate with 25 mM sodium
citrate, 0.5% N-laurosylsarcosine and 0.1 M 2-mercaptoethanol
(pH 7.0) for RNA extraction.
Determination of Cytokine mRNA Expression Levels
Total RNA was extracted as described [30] and stored at
280uC. Concentrations of IL-6, IL-8, TNF-a and TGF-b1
mRNAs were determined in triplicate by real-time quantitative
RT-PCR assays with RNA copy standards as described [30–32].
The 18S rRNA content was determined in all samples using a real-
time quantitative RT-PCR kit (Applied Biosystems) and results
were expressed as mRNA copies per 18S rRNA unit.
Determination of Secreted Cytokines
Concentrations of IL-8 and TNF-a proteins were determined in
duplicates of tissue culture medium collected from the lower
chamber of monolayer cultures by using the Endogen Human IL-
8 and TNF-a ELISA Kits, respectively (Pierce Biotechnology,
Rockford, IL). Results are given as the concentration determined
by ELISA in culture medium from the lower chamber of tight
monolayer cultures after subtraction of the concentration in the
broth control in the respective experiment.
Cytolysis Assay
Cell death in monolayer cultures was estimated as the LDH
activity released to the lower chambers using the Cytotoxicity
Detection Kit (LDH) (Roche Applied Science, Mannheim,
Germany). Cytolysis (%) was calculated as: [(experimental
OD405 value - low control OD405 value)/(high control OD405
value - low control OD405 value)] 6100. ‘‘Low control’’ is the
spontaneous release of LDH from parallel tight monolayers in
complete culture medium and ‘‘high control’’ the LDH activity in
supernatants from parallel tight monolayers incubated in the
presence of 2% Triton X100.
Hemolytic Activity Assay
Hemolysis was estimated as release of hemoglobin as described
[34]. Rabbit red blood cells (8%) were suspended in PBS
containing 0.1% gelatin. Fifty ml of the suspension was loaded
into the wells of a 96-well microtiter plate containing 50 mlo f
serially diluted bacterial culture supernatants. The microtiter plate
was incubated at 37uC for 120 min and subsequently centrifuged
at 1800 x g for 10 min. Fifty ml from each well was transferred to
a new plate and the absorbance at 540 nm was measured
spectrophotometrically.
SDS-PAGE and Western Blot Analysis
Bacterial strains were grown in LB and BHI media with
aeration by shaking at 30uC for 24 h. Bacteria were harvested by
centrifugation at 10,000 x g for 10 min at 4uC. The culture
supernatant fluid was precipitated with 10% trichloroacetic acid
(TCA). Briefly, 1 volume (250 ml) of 50% TCA was added to 4
volumes (1 ml) of protein sample. The protein-TCA mixture was
kept on ice for 15 min, and subsequently, the tube was centrifuged
at 15,000 x g for 5 min. The supernatant was removed, the protein
pellet was washed with 200 ml of cold acetone, and the tube was
centrifuged at 15,000 x g for 5 min. The resulting pellets were
dissolved in SDS sample buffer and the protein samples were
subjected to polyacrylamide gel electrophoresis and then blotted
onto a PVDF membrane [34]. Proteins were identified using anti-
VCC [19] and anti-PrtV [10] polyclonal rabbit antisera at a final
dilution of 1:10,000 and 1:200,000 respectively. Anti-rabbit Ig
horseradish peroxidase-conjugate (GE Healthcare) was used as a
secondary antibody at a final dilution of 1:20,000. The ECL+
chemiluminescence system (GE Healthcare) was used to detect the
level of chemiluminescence that was then monitored using a Fluor-
S MultiImager (BioRad) and by autoradiography.
Statistical Analyses
Statistical analysis of changes in TER, LDH release, cytokine
mRNA expression levels and IL-8 protein concentrations caused
by bacterial culture supernatants and the VCC and PrtV proteins
compared to LB or BHI broth controls was performed using
Student’s t-test. Statistical significance of changes in hemolytic
activity of DprtV and DhapR compared to C6706wt was evaluated
using one-way ANOVA with Dunnett’s post-test at each dilution.
Two-sided assays were used throughout. Differences with a p-
value #0.05 were considered statistically significant. Results are
given as mean61SD.
Supporting Information
Figure S1 Effects of V. cholerae V11 strain culture supernatants
on permeability and IL-8 mRNA expression. Supernatants from
24 hours cultures of non-01/non-0139 V. cholerae strain V11 grown
in LB broth (LB) or BHI broth (BHI) were added to the apical side
of polarized tight monolayers of T84 cells. Changes in transepi-
thelial electrical resistance (TER) as percent of TER at onset of
incubation (a), cell death determined as percent of released LDH
(b), expression levels of IL-8 (c) and TNF-a (d) mRNAs as
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after 5 hours incubation. Bars and whiskers indicate mean + 1SD
of three independent experiments. Black insert bars in (c) and (d)
indicates the cytokine mRNA levels in LB and BHI broth controls,
respectively.
Found at: doi:10.1371/journal.pone.0007806.s001 (0.41 MB TIF)
Figure S2 Immunoblot analyses of VCC and PrtV of V. cholerae
grown in LB and BHI media. V. cholerae O1 strain C6706 (C6706),
non-O1/non-O139 strain V11 (V11) and C6706 strain VCC
deletion mutant (Dvcc) were grown in LB and BHI media for
24 hours and proteins from 1 ml culture supernatants were
analysed by immunoblot using anti-VCC and anti-PrtV polyclonal
antisera.
Found at: doi:10.1371/journal.pone.0007806.s002 (0.29 MB TIF)
Text S1 Supplementary Text S1
Found at: doi:10.1371/journal.pone.0007806.s003 (0.03 MB
DOC)
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